Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ONCY
XLO
Add up to 3 more stocks
ONCY
Oncolytics Biotech Inc.
+0.18%
$0.60+0.00Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$60.02M
52W Range
$0.58 - $1.39
XLO
Xilio Therapeutics, Inc.
-1.21%
$9.00-0.11Delayed quote: Oct 6, 2026, 3:59 PM EDT
Market Cap
$59.18M
52W Range
$6.47 - $12.59
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | N/A | 0.82 |
| P/S Ratio | N/A | 0.92 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 99.5% |
| Operating Margin | 0.0% | -95.9% |
| Net Margin | 0.0% | -34.1% |
| ROE | N/A | -30.2% |
| ROA | -393.7% | -14.2% |
| ROIC | -1235.5% | -26.1% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.35 | 4.25 |
| Quick Ratio | 1.35 | 4.25 |
| Debt/Equity | N/A | 0.09 |
| Interest Coverage | N/A | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.